Avecho targets insomnia in drive for S3 registration by Martin Lane May 28, 2021May 28, 2021 Avecho Biotechnology has targeted insomnia as the indication that will underpin pivotal phase III clinical trials […]
Avecho begins observational study to test oral CBD formulation on human patients by Martin Lane January 4, 2021January 4, 2021
Avecho aims to improve CBD absorption and boost efficacy at low doses by Emma Castle December 9, 2020December 10, 2020
